Coegin Pharma AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 20,000 compared to SEK 470,000 a year ago. Operating loss was SEK 10.113 million compared to SEK 1.824 million a year ago. Net loss was SEK 10.125 million compared to SEK 1.859 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.49 a year ago.